Arndt Vogel

35PUBLICATIONS
307CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 26, 2026
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

|Sep 01, 2026
Sequencing of Fibroblast Growth Factor Receptor Inhibitors in Cholangiocarcinoma: A Review of Published Cases.

|Jun 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|Mar 03, 2026
Perioperative approaches for patients with biliary tract cancer.

Anudari Zorigtbaatar, Zhihao Li, Christian T J Magyar

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

Pageof 6

Frequent Collaborators

10 joint publications

Anna Saborowski

7 joint publications

Lorenza Rimassa

5 joint publications

Masatoshi Kudo

4 joint publications

Gonzalo Sapisochin